<DOC>
	<DOCNO>NCT02174757</DOCNO>
	<brief_summary>Periodontitis multifactorial disease lead destruction support tissue teeth result pocket formation , recession . Since primary etiological factor periodontal disease bacteria supra sub gingival biofilm , effort disease prevention treatment mainly focus pathogen reduction strengthen epithelial barrier , thus contribute decrease susceptibility infection . Due emergence antibiotic resistance frequent recolonization treat site pathogenic bacteria , need new treatment paradigm introduce periodontal disease . The need fulfil introduction Probiotics Bacterial Replacement Therapy . The term probiotic derive Greek , mean `` life '' microorganism proven exert health promoting influence humans animal . Food Agriculture Organization WHO state potential probiotic food provide health benefit specific strain safe human use .</brief_summary>
	<brief_title>Effect Probiotic Inersan Doxycycline Chronic Periodontitis</brief_title>
	<detailed_description />
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<criteria>1 . Subjects sex 2 . Age 25 60 yr 3 . Subjects mild moderate chronic periodontitis , define probe pocket depth â‰¥ 5mm &gt; 30 % probe site 4 . Subjects good general health 1 . Antibiotic therapy past 2 month 2 . Allergic doxycycline probiotic 3 . Subjects diabetic mellitus , hypertension psychiatric disorder 4 . Subjects pregnant/ lactate 5 . Smokers and/or alcoholic 6 . Subjects undergone periodontal therapy within last 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>